Skip to main content
Top
Published in: BMC Psychiatry 1/2021

Open Access 01-12-2021 | Alzheimer's Disease | Study protocol

Targeting hippocampal hyperactivity with real-time fMRI neurofeedback: protocol of a single-blind randomized controlled trial in mild cognitive impairment

Authors: Katharina Klink, Urs Jaun, Andrea Federspiel, Marina Wunderlin, Charlotte E. Teunissen, Claus Kiefer, Roland Wiest, Frank Scharnowski, Ronald Sladky, Amelie Haugg, Lydia Hellrung, Jessica Peter

Published in: BMC Psychiatry | Issue 1/2021

Login to get access

Abstract

Background

Several fMRI studies found hyperactivity in the hippocampus during pattern separation tasks in patients with Mild Cognitive Impairment (MCI; a prodromal stage of Alzheimer’s disease). This was associated with memory deficits, subsequent cognitive decline, and faster clinical progression. A reduction of hippocampal hyperactivity with an antiepileptic drug improved memory performance. Pharmacological interventions, however, entail the risk of side effects. An alternative approach may be real-time fMRI neurofeedback, during which individuals learn to control region-specific brain activity. In the current project we aim to test the potential of neurofeedback to reduce hippocampal hyperactivity and thereby improve memory performance.

Methods

In a single-blind parallel-group study, we will randomize n = 84 individuals (n = 42 patients with MCI, n = 42 healthy elderly volunteers) to one of two groups receiving feedback from either the hippocampus or a functionally independent region. Percent signal change of the hemodynamic response within the respective target region will be displayed to the participant with a thermometer icon. We hypothesize that only feedback from the hippocampus will decrease hippocampal hyperactivity during pattern separation and thereby improve memory performance.

Discussion

Results of this study will reveal whether real-time fMRI neurofeedback is able to reduce hippocampal hyperactivity and thereby improve memory performance. In addition, the results of this study may identify predictors of successful neurofeedback as well as the most successful regulation strategies.

Trial registration

The study has been registered with clinicaltrials.gov on the 16th of July 2019 (trial identifier: NCT04020744).
Literature
1.
go back to reference Ritchie K, Carrière I, Berr C, Amieva H, Dartigues J-F, Ancelin M-L, et al. The clinical picture of Alzheimer’s disease in the decade before diagnosis: clinical and biomarker trajectories. J Clin Psychiatry. 2016;77:e305–11.CrossRef Ritchie K, Carrière I, Berr C, Amieva H, Dartigues J-F, Ancelin M-L, et al. The clinical picture of Alzheimer’s disease in the decade before diagnosis: clinical and biomarker trajectories. J Clin Psychiatry. 2016;77:e305–11.CrossRef
2.
go back to reference Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–59.CrossRef Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–59.CrossRef
3.
go back to reference Aizenstein HJ, Klunk WE. Where is hippocampal activity in the cascade of Alzheimer’s disease biomarkers? Brain. 2015;138:831–3.CrossRef Aizenstein HJ, Klunk WE. Where is hippocampal activity in the cascade of Alzheimer’s disease biomarkers? Brain. 2015;138:831–3.CrossRef
4.
go back to reference Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.CrossRef Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.CrossRef
5.
go back to reference Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimer’s disease dementia. Trends Neurosci. 2011;34:430–42.CrossRef Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimer’s disease dementia. Trends Neurosci. 2011;34:430–42.CrossRef
6.
go back to reference O’Brien JL, O’Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 2010;74:1969–76.CrossRef O’Brien JL, O’Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 2010;74:1969–76.CrossRef
7.
go back to reference Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74:467–74.CrossRef Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74:467–74.CrossRef
8.
go back to reference Corona-Long CA, Tran TT, Chang E, Speck CL, Gallagher M, Bakker A. Comparison of male and female patients with amnestic mild cognitive impairment: hippocampal hyperactivity and pattern separation memory performance. Alzheimers Dement. 2020;12. https://doi.org/10.1002/dad2.12043. Corona-Long CA, Tran TT, Chang E, Speck CL, Gallagher M, Bakker A. Comparison of male and female patients with amnestic mild cognitive impairment: hippocampal hyperactivity and pattern separation memory performance. Alzheimers Dement. 2020;12. https://​doi.​org/​10.​1002/​dad2.​12043.
9.
go back to reference Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, et al. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain. 2015;138(Pt 4):1023–35.CrossRef Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, et al. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain. 2015;138(Pt 4):1023–35.CrossRef
10.
go back to reference Sitaram R, Ros T, Stoeckel L, Haller S, Scharnowski F, Lewis-Peacock J, et al. Closed-loop brain training: the science of neurofeedback. Nat Rev Neurosci. 2017;18:86–100.CrossRef Sitaram R, Ros T, Stoeckel L, Haller S, Scharnowski F, Lewis-Peacock J, et al. Closed-loop brain training: the science of neurofeedback. Nat Rev Neurosci. 2017;18:86–100.CrossRef
11.
go back to reference Weiskopf N. Real-time fMRI and its application to neurofeedback. Neuroimage. 2012;62:682–92.CrossRef Weiskopf N. Real-time fMRI and its application to neurofeedback. Neuroimage. 2012;62:682–92.CrossRef
12.
go back to reference Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.CrossRef Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.CrossRef
13.
go back to reference Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014;275:214–28.CrossRef Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014;275:214–28.CrossRef
14.
go back to reference Yesavage JA, Sheikh JI. 9/geriatric depression scale (GDS). Clin Gerontol. 1986;5:165–73.CrossRef Yesavage JA, Sheikh JI. 9/geriatric depression scale (GDS). Clin Gerontol. 1986;5:165–73.CrossRef
15.
go back to reference Gillebert CR, Mantini D, Thijs V, Sunaert S, Dupont P, Vandenberghe R. Lesion evidence for the critical role of the intraparietal sulcus in spatial attention. Brain. 2011;134(Pt 6):1694–709.CrossRef Gillebert CR, Mantini D, Thijs V, Sunaert S, Dupont P, Vandenberghe R. Lesion evidence for the critical role of the intraparietal sulcus in spatial attention. Brain. 2011;134(Pt 6):1694–709.CrossRef
16.
go back to reference Sorger B, Scharnowski F, Linden DEJ, Hampson M, Young KD. Control freaks: towards optimal selection of control conditions for fMRI neurofeedback studies. NeuroImage. 2019;186:256–65.CrossRef Sorger B, Scharnowski F, Linden DEJ, Hampson M, Young KD. Control freaks: towards optimal selection of control conditions for fMRI neurofeedback studies. NeuroImage. 2019;186:256–65.CrossRef
17.
go back to reference Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med. 2000;343:450–6.CrossRef Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med. 2000;343:450–6.CrossRef
18.
go back to reference Leal SL, Landau SM, Bell RK, Jagust WJ. Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife. 2017;6:e22978.CrossRef Leal SL, Landau SM, Bell RK, Jagust WJ. Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife. 2017;6:e22978.CrossRef
19.
go back to reference Verberk IMW, Thijssen E, Koelewijn J, Mauroo K, Vanbrabant J, de Wilde A, et al. Combination of plasma amyloid beta (1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res Ther. 2020;12:118.CrossRef Verberk IMW, Thijssen E, Koelewijn J, Mauroo K, Vanbrabant J, de Wilde A, et al. Combination of plasma amyloid beta (1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res Ther. 2020;12:118.CrossRef
20.
go back to reference Kiefer C, Abela E, Schindler K, Wiest R. Focal epilepsy: MR imaging of nonhemodynamic field effects by using a phase-cycled stimulus-induced rotary saturation approach with spin-lock preparation. Radiology. 2016;280:237–43.CrossRef Kiefer C, Abela E, Schindler K, Wiest R. Focal epilepsy: MR imaging of nonhemodynamic field effects by using a phase-cycled stimulus-induced rotary saturation approach with spin-lock preparation. Radiology. 2016;280:237–43.CrossRef
21.
go back to reference Peirce J, Gray JR, Simpson S, MacAskill M, Höchenberger R, Sogo H, et al. PsychoPy2: experiments in behavior made easy. Behav Res. 2019;51:195–203.CrossRef Peirce J, Gray JR, Simpson S, MacAskill M, Höchenberger R, Sogo H, et al. PsychoPy2: experiments in behavior made easy. Behav Res. 2019;51:195–203.CrossRef
23.
go back to reference Koush Y, Ashburner J, Prilepin E, Sladky R, Zeidman P, Bibikov S, et al. OpenNFT: an open-source Python/Matlab framework for real-time fMRI neurofeedback training based on activity, connectivity and multivariate pattern analysis. NeuroImage. 2017;156:489–503.CrossRef Koush Y, Ashburner J, Prilepin E, Sladky R, Zeidman P, Bibikov S, et al. OpenNFT: an open-source Python/Matlab framework for real-time fMRI neurofeedback training based on activity, connectivity and multivariate pattern analysis. NeuroImage. 2017;156:489–503.CrossRef
24.
go back to reference Johnson KA, Hartwell K, LeMatty T, Borckardt J, Morgan PS, Govindarajan K, et al. Intermittent “real-time” fMRI feedback is superior to continuous presentation for a motor imagery task: a pilot study. J Neuroimaging. 2012;22:58–66.CrossRef Johnson KA, Hartwell K, LeMatty T, Borckardt J, Morgan PS, Govindarajan K, et al. Intermittent “real-time” fMRI feedback is superior to continuous presentation for a motor imagery task: a pilot study. J Neuroimaging. 2012;22:58–66.CrossRef
25.
go back to reference Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55.CrossRef Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55.CrossRef
26.
go back to reference Lacy JW, Yassa MA, Stark SM, Muftuler LT, Stark CEL. Distinct pattern separation related transfer functions in human CA3/dentate and CA1 revealed using high-resolution fMRI and variable mnemonic similarity. Learn Mem. 2011;18:15–8.CrossRef Lacy JW, Yassa MA, Stark SM, Muftuler LT, Stark CEL. Distinct pattern separation related transfer functions in human CA3/dentate and CA1 revealed using high-resolution fMRI and variable mnemonic similarity. Learn Mem. 2011;18:15–8.CrossRef
28.
go back to reference Sulzer J, Haller S, Scharnowski F, Weiskopf N, Birbaumer N, Blefari ML, et al. Real-time fMRI neurofeedback: progress and challenges. NeuroImage. 2013;76:386–99.CrossRef Sulzer J, Haller S, Scharnowski F, Weiskopf N, Birbaumer N, Blefari ML, et al. Real-time fMRI neurofeedback: progress and challenges. NeuroImage. 2013;76:386–99.CrossRef
29.
go back to reference Helmstaedter C, Lendt M, Lux S. Verbaler Lern- und Merkfähigkeitstest. Göttingen: Hogrefe; 2001. Helmstaedter C, Lendt M, Lux S. Verbaler Lern- und Merkfähigkeitstest. Göttingen: Hogrefe; 2001.
30.
go back to reference McNair DM, Lorr M, Droppleman LF. Profile of mood states. San Diego: Educational and Industrial Testing Service; 1971. McNair DM, Lorr M, Droppleman LF. Profile of mood states. San Diego: Educational and Industrial Testing Service; 1971.
31.
go back to reference Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004;43(Pt 3):245–65.CrossRef Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004;43(Pt 3):245–65.CrossRef
32.
go back to reference Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60.CrossRef Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60.CrossRef
33.
go back to reference Hawkinson JE, Ross AJ, Parthasarathy S, Scott DJ, Laramee EA, Posecion LJ, et al. Quantification of adverse events associated with functional MRI scanning and with real-time fMRI-based training. IntJ Behav Med. 2012;19:372–81.CrossRef Hawkinson JE, Ross AJ, Parthasarathy S, Scott DJ, Laramee EA, Posecion LJ, et al. Quantification of adverse events associated with functional MRI scanning and with real-time fMRI-based training. IntJ Behav Med. 2012;19:372–81.CrossRef
34.
go back to reference Megumi F, Yamashita A, Kawato M, Imamizu H. Functional MRI neurofeedback training on connectivity between two regions induces long-lasting changes in intrinsic functional network. Front Hum Neurosci. 2015;9:160.CrossRef Megumi F, Yamashita A, Kawato M, Imamizu H. Functional MRI neurofeedback training on connectivity between two regions induces long-lasting changes in intrinsic functional network. Front Hum Neurosci. 2015;9:160.CrossRef
35.
go back to reference Scheinost D, Stoica T, Saksa J, Papademetris X, Constable RT, Pittenger C, et al. Orbitofrontal cortex neurofeedback produces lasting changes in contamination anxiety and resting-state connectivity. Transl Psychiatry. 2013;3:e250.CrossRef Scheinost D, Stoica T, Saksa J, Papademetris X, Constable RT, Pittenger C, et al. Orbitofrontal cortex neurofeedback produces lasting changes in contamination anxiety and resting-state connectivity. Transl Psychiatry. 2013;3:e250.CrossRef
Metadata
Title
Targeting hippocampal hyperactivity with real-time fMRI neurofeedback: protocol of a single-blind randomized controlled trial in mild cognitive impairment
Authors
Katharina Klink
Urs Jaun
Andrea Federspiel
Marina Wunderlin
Charlotte E. Teunissen
Claus Kiefer
Roland Wiest
Frank Scharnowski
Ronald Sladky
Amelie Haugg
Lydia Hellrung
Jessica Peter
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-021-03091-8

Other articles of this Issue 1/2021

BMC Psychiatry 1/2021 Go to the issue